Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients

• Main Authors: Wacharee Seeherunvong, Obioma Nwobi, Carolyn L. Abitbol, Jayanthi Chandar, José Strauss, Gastón Zilleruelo
• Other Authors: Mahidol University
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/23585

Secondary hyperparathyroidism (SHPT) remains a treatment dilemma in pediatric dialysis patients. Recent experience with paricalcitol (P), a vitamin D analogue, in adults with SHPT has shown equal efficacy and improved survival compared to traditional treatment with calcitriol (C). We present our exp...